Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sterilization composition containing cyclohexyl flusulfamide

A technology of cyclazone and composition, applied to crop diseases, in the field of bactericidal composition containing cyclazone, to achieve the effect of reducing residue, high activity, and reducing the amount of pesticides used

Inactive Publication Date: 2014-03-12
SHAANXI MEIBANG PHARMA GRP CO LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After research by the inventors, it was found that the compounding of cyclazone, fluconazole, polyoxamycin, prochloraz or its salts, carbendazim, and thiophanate-methyl had a good effect within a certain range. Synergistic effect, and there is no relevant report about the compounding of cyclazone, flufenazole, polyoxamycin, prochloraz or its salts, carbendazim, and thiophanate-methyl at home and abroad.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sterilization composition containing cyclohexyl flusulfamide
  • Sterilization composition containing cyclohexyl flusulfamide
  • Sterilization composition containing cyclohexyl flusulfamide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1~14

[0040] Embodiment 1~14 wettable powder

[0041] Mix cyclohexasulfame, active ingredient B, dispersant, wetting agent, and filler, mix evenly in a mixing tank, pulverize through a jet mill and mix evenly, then the wettable powder product of the present invention can be made . See Table 1 for details.

[0042] Table 1 Embodiment 1~14 each component and content

[0043]

Embodiment 15~28

[0044] Embodiment 15~28 water dispersible granules

[0045] Combine cyclohexasulfame, active ingredient B, dispersant, wetting agent, disintegrant, and filler together through airflow pulverization to obtain the required particle size, and then add binder (optional) and other additives to obtain Granulation materials. The water-dispersible granule product of the present invention is obtained by quantitatively sending the material into a fluidized bed granulation dryer for granulation and drying. See Table 2 for details.

[0046] Table 2 Embodiment 15~28 each component and content

[0047]

[0048] The new preparation can be obtained by exchanging flufenazole, polyoxamycin, prochloraz or its salts, carbendazim, and thiophanate-methyl in Tables 1 to 2.

Embodiment 29~42

[0049] Embodiment 29~42 suspending agent

[0050] Dispersant, wetting agent, thickener (can be added or not), defoamer, antifreeze (can be added or not) are mixed evenly through high-speed shearing, add cyclohexasulfame and active ingredient B, and use Make up the balance with ionized water, and ball mill in a ball mill for 2 to 3 hours, so that the particle size is all below 5 μm, and the suspension product of the present invention is obtained. See Table 3 for details.

[0051] Table 3 Embodiment 29~42 each component and content

[0052]

[0053] The new preparation can be obtained by exchanging flufenazole, polyoxamycin, prochloraz, carbendazim, and thiophanate-methyl in the table.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a sterilization composition containing cyclohexyl flusulfamide. The sterilization composition comprises an active ingredient A and an active ingredient B; the active ingredient A is cyclohexyl flusulfamide; the active ingredient B is one compound randomly selected form triflumizole, polyoxins, prochloraz or a salt thereof, carbendazim, and thiophanate methyl; and the weight ratio of the active ingredient A to the active ingredient B is 1:60-80:1. The sterilization composition possesses relatively high activity on a plurality of diseases of a plurality of crops, and obvious synergistic effect; and sterilization spectrum is widened. In addition, the sterilization composition possesses characteristics such as small dose, rainwater wash resistance, and obvious synergy.

Description

technical field [0001] The invention belongs to the technical field of pesticides, and relates to the application of a fungicidal composition containing cyclohexasulfame to crop diseases. technical background [0002] Cyclohexasulfame chemical name: N-(2-trifluoromethyl-4-chlorophenyl)-a-oxocyclohexylsulfonamide. It has strong preventive, therapeutic and osmotic activities, and has high persistence. The field test results show that cyclazone can effectively control Botrytis cinerea, rape sclerotinia, cucumber brown spot and scab. [0003] Salts of prochloraz include prochloraz manganese salt, prochloraz copper salt, and prochloraz zinc salt. [0004] In the actual process of agricultural production, the most likely problem in disease control is the emergence of disease resistance. Combination of ingredients from different varieties is a common method for controlling resistant diseases. Different ingredients are compounded, and according to the actual application effect, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A01N47/38A01N41/06A01N43/50A01N47/12A01N47/18A01N47/34A01P3/00
Inventor 张伟钟小丹
Owner SHAANXI MEIBANG PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products